期刊文献+

布地奈德雾化吸入治疗毛细支气管炎疗效观察 被引量:5

The curative effect of budesonide inhalation on bronchiolitis
下载PDF
导出
摘要 目的探讨吸入布地奈德治疗毛细支气管炎的疗效。方法将50例轻中症毛细支气管炎患儿随机分为治疗组25例,对照组25例,在常规治疗的基础上,治疗组吸入布地奈德混悬液加万托林雾化溶液,对照组单纯吸入万托林雾化溶液,另外静滴琥珀酸氢考,观察哮鸣音减少、消失及住院时间。结果两组间比较哮鸣音减少、消失及住院时间,差异无统计学意义(P>0.05)。结论吸入布地奈德治疗轻中症毛细支气管炎疗效肯定,安全,全身不良反应轻,值得推广使用。静滴琥珀酸氢考不能获得更好的疗效。 Objective To explore the curative effects of inhalation of budesonide suspension in treating bronchiolitis.Methods 50 cases of mild to moderate bronchiolitis were devided into two groups randomly with 25 in control group and 25 cases in treating group.Both groups were treated with routine therapy while 25 cases in control group were given inhalation of budesonide suspension and ventolin.25 cases in treating group were given inhalation of ventolin and hydrocortisone sodium succinate.we observed the time of reduction and disappearance of wheeze as well as the duration of hospitalization.Results No significant difference exists between the two groups comparing the time of reduction and disappearance of wheeze and the duration of hospitalization(P〉 0.05).Conclusion Inhalation of budesonide suspension has positive effective in treating mild to moderate bronchiolitis,safe and has few side effects.as well as be worthwhile to widely spread.giving hydrocortisone sodium succinate intravenously can not acquire better efficacy.
作者 张红梅
出处 《临床肺科杂志》 2010年第8期1111-1112,共2页 Journal of Clinical Pulmonary Medicine
关键词 毛细支气管炎 布地奈德 琥珀酸氢考 bronchiolitis budesonide hydrocortisone sodium succinate
  • 相关文献

参考文献5

二级参考文献30

  • 1徐玮,董伟.支气管哮喘与免疫[J].标记免疫分析与临床,2004,11(2):113-115. 被引量:4
  • 2高飞絮,张国龙,王江东,秦殊.哮喘患者细胞因子的改变与治疗[J].医药论坛杂志,2006,27(1):3-4. 被引量:4
  • 3中华医学会呼吸病学分会.哮喘组支气管哮喘防治指南[J].中华结核和呼吸杂志,2008,31(3):177-185. 被引量:1
  • 4Pauwels RA, Pedersen S, Busse WW, et al. START Investigation Group. Early intervention with budesonide in mild persistent asthma : a randomized, double blind trial. Lancet, 2003,361 : 1071 - 1076. 被引量:1
  • 5OByrne PM, Bisgard H, Gohart PP, et al. Budesonide/Formoterol combination Therapy as Both Maintenance and Reliever Medication in Asthma. Am J Respir Crit Care Med,2004,171 : 129 - 136. 被引量:1
  • 6Pauwels RA, Lofdahl CG, Postma DS, et al. Effect of inhaled formoterol and budenoside on exacerbation of asthma: Formoterol And Corticosteroids Establishing Therapy [ FACET ] International study Group. N Eng J Med, 1997,337 : 1405 - 1411. 被引量:1
  • 7OByrne PM, Barnes PJ, Rudriguoz-Rosin R, et al. Tow dose inhaled budesonide and formoterol in mild persistent asthma: The OPTIMA randomized trial. Am J Respir Crit Care Med,2001,164: 1392 - 1397. 被引量:1
  • 8Bateman ED, Bousley HA, Bousquet J, et al. Can Guideline-defined Asthma Control be achieved. The Gaining Optimal Asthma Control Study (GOAL). Am J Respir Crit Care Med,2004,170: 836 - 844. 被引量:1
  • 9Fitz Gerald JM, Boulet LP, Richard MA. The CONCEPT Trial: A 1-year multicenter, Randomized, Double-blind, Double-Dummy comparison of a stable dosing Regimen of Formoterol/Budesonide in Adult with persistent Asthma. Clin Ther,2003,27 (4) :393 - 406. 被引量:1
  • 10Nelson HS, Weiss ST, Bleecker ER, et al. The SMART Study Group. The Salmeterol Muhicenter Asthma Research Trial. Chest, 2006,129 : 15 - 26. 被引量:1

共引文献187

同被引文献38

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部